ArticleMedical oncology (Northwood, London, England)2015

Erratum to: single-agent bevacizumab is an effective treatment in recurrent glioblastoma.

Ilhan Hacibekiroglu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.